journal article·2018-02-17Open access

Gold nanoparticles applications: from artificial enzyme till drug delivery

Kazem Golchin, Jafar Golchin, Shahrooz Ghaderi, Neda Alidadiani, Sajjad Eslamkhah, Masoud Eslamkhah, Soodabeh Davaran, Abolfazl Akbarzadeh

Abstract

Today, nano-medicine promotes new therapeutics and diagnostics tools, including sensing of biomolecules as a biosensor, cancer chemotherapy and drug or gene delivery. Because of small size and biocompatibility of gold nanoparticles (GNPs), they become a good candidate for biological application. Also, thanks to their biological and chemical properties, they can mimic function of some enzymes including super oxide dismutase (SOD), esterase, etc. Also, biomaterials and bioengineering have grown so fast since the last decade for many therapeutic applications such as tissue regeneration. Among these cutting edge technology, nanomaterials find the way to becoming a very powerful tool for using in many fields of researchers including biosensing, gene therapy and chemotherapy. In this review, we focused on some biological applications of GNPs in biology and medicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran;

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran;

Division of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;

Division of Clinical Biochemistry and Laboratory Medicine, Tabriz University of Medical Sciences, Tabriz, Iran;

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

References (61)

Show source-provided references
1. 10.1002/adma.20140023810.1002/adma.201400238 ↗
2. 10.1002/chem.20050105110.1002/chem.200501051 ↗
3. 10.1021/ja034775u10.1021/ja034775u ↗
4. 10.1039/c0cc02698k10.1039/c0cc02698k ↗
5. 10.1021/ac103283p10.1021/ac103283p ↗
6. 10.1021/ac902198v10.1021/ac902198v ↗
7. 10.1039/b712170a10.1039/b712170a ↗
8. 10.1002/anie.20060373510.1002/anie.200603735 ↗
9. 10.1016/j.bios.2008.12.00910.1016/j.bios.2008.12.009 ↗
10. 10.1016/j.aca.2004.10.00710.1016/j.aca.2004.10.007 ↗
11. 10.1002/cbic.20060012910.1002/cbic.200600129 ↗
12. 10.1007/s11468-011-9228-110.1007/s11468-011-9228-1 ↗
13. 10.1021/ar500078f10.1021/ar500078f ↗
14. Londoño Ramírez H. Upconverting and plasmonic nanomaterials for targeted detection and treatment of bladder cancer. 2013.
15. 10.1016/j.nano.2013.07.00110.1016/j.nano.2013.07.001 ↗
16. Jain S · Brit J Radiol · 2014 · 5 · 101
17. 10.2217/nnm.12.16510.2217/nnm.12.165 ↗
18. 10.1038/nnano.2006.5110.1038/nnano.2006.51 ↗
19. 10.1002/smll.20110101810.1002/smll.201101018 ↗
20. 10.1021/ja110833r10.1021/ja110833r ↗
21. 10.3109/21691401.2015.102962710.3109/21691401.2015.1029627 ↗
22. 10.1038/mt.2014.3010.1038/mt.2014.30 ↗
23. 10.1021/ac300815c10.1021/ac300815c ↗
24. 10.1021/ac300405510.1021/ac3004055 ↗
25. 10.1021/acsami.6b0296910.1021/acsami.6b02969 ↗
26. 10.1016/j.critrevonc.2015.10.01510.1016/j.critrevonc.2015.10.015 ↗
27. 10.1002/adma.20040110910.1002/adma.200401109 ↗
28. 10.1021/ja043547c10.1021/ja043547c ↗
29. 10.1021/ac300867s10.1021/ac300867s ↗
30. 10.1016/j.biomaterials.2012.10.01010.1016/j.biomaterials.2012.10.010 ↗
31. 10.1080/00387010.2011.64944010.1080/00387010.2011.649440 ↗
32. 10.1021/cm100393v10.1021/cm100393v ↗
33. 10.1166/jns.2012.101810.1166/jns.2012.1018 ↗
34. 10.1016/j.scitotenv.2013.05.01810.1016/j.scitotenv.2013.05.018 ↗
35. 10.1007/s12274-015-0904-x10.1007/s12274-015-0904-x ↗
36. 10.1016/j.msec.2016.10.01310.1016/j.msec.2016.10.013 ↗
37. 10.3109/21691401.2014.95510710.3109/21691401.2014.955107 ↗
38. 10.3109/21691401.2014.95363210.3109/21691401.2014.953632 ↗
39. 10.3109/21691401.2014.96882210.3109/21691401.2014.968822 ↗
40. Majidi S · Artif Cells Nanomed Biotechnol · 2016 · 44 · 118610.3109/21691401.2014.982802 ↗
41. 10.1016/j.bios.2016.01.09010.1016/j.bios.2016.01.090 ↗
42. 10.1515/zpch-2016-086410.1515/zpch-2016-0864 ↗
43. 10.1016/j.snb.2016.11.09610.1016/j.snb.2016.11.096 ↗
44. 10.1016/j.snb.2016.08.07910.1016/j.snb.2016.08.079 ↗
45. 10.3762/bjnano.8.110.3762/bjnano.8.1 ↗
46. 10.1016/j.bios.2016.07.04710.1016/j.bios.2016.07.047 ↗
47. 10.1016/j.snb.2016.07.06710.1016/j.snb.2016.07.067 ↗
48. 10.1016/j.apcatb.2016.09.00210.1016/j.apcatb.2016.09.002 ↗
49. 10.1016/j.nano.2016.08.02610.1016/j.nano.2016.08.026 ↗
50. 10.1007/s12274-016-1265-910.1007/s12274-016-1265-9 ↗
51. 10.1016/j.snb.2016.08.11710.1016/j.snb.2016.08.117 ↗
52. 10.1016/j.ejps.2016.10.01110.1016/j.ejps.2016.10.011 ↗
53. 10.1016/j.bios.2016.12.04310.1016/j.bios.2016.12.043 ↗
54. 10.3109/21691401.2014.97180710.3109/21691401.2014.971807 ↗
55. 10.1016/j.bios.2016.07.06910.1016/j.bios.2016.07.069 ↗
56. 10.1515/zpch-2016-087910.1515/zpch-2016-0879 ↗
57. 10.3109/21691401.2014.97180510.3109/21691401.2014.971805 ↗
58. 10.1016/j.snb.2016.07.01610.1016/j.snb.2016.07.016 ↗
59. 10.1016/j.colsurfb.2016.10.01710.1016/j.colsurfb.2016.10.017 ↗
60. Liang S · Synfacts · 2017 · 13 · 0113
61. 10.1002/adma.20140510510.1002/adma.201405105 ↗